Products - Chronic liver disease | Topic | NICE

Showing 5 products

Date | Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

Odevixibat for treating progressive familial intrahepatic cholestasis (HST17)
Product type:
Guidance
Programme:
Highly specialised technologies guidance
Published:
22 February 2022
MRI-based technologies for assessing non-alcoholic fatty liver disease
Status:
In development
Programme:
Diagnostics guidance
Expected publication date:
15 December 2022
Cirrhosis in over 16s: assessment and management
Status:
In development
Programme:
NICE guideline
Expected publication date:
7 February 2024
Obeticholic acid for treating liver fibrosis in people with steatohepatitis [ID1645]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
OrganOx metra for liver transplant [ID5116]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC